InvestorsHub Logo
Followers 4
Posts 1195
Boards Moderated 0
Alias Born 10/03/2015

Re: ronpopeil post# 514

Saturday, 12/03/2016 2:15:18 PM

Saturday, December 03, 2016 2:15:18 PM

Post# of 977
It is a win in the CD47 space. First PR @ .05mg/Kg shows TTI621's potency. CELG , 47 and Surface Onco are tied up by antigen sink. Every pharma with anti PD1 should be interested.